Overview

Determining the Safety and Effectiveness of Olanzapine in Children and Adolescents

Status:
Terminated
Trial end date:
2007-04-01
Target enrollment:
Participant gender:
Summary
This study will examine the safety and effectiveness of the antipsychotic drug olanzapine in children and adolescents with bipolar disorder or psychosis.
Phase:
N/A
Details
Lead Sponsor:
Massachusetts General Hospital
Collaborator:
National Institute of Mental Health (NIMH)
Treatments:
Olanzapine